chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My daughter was administered the flu shot at her well check-up.  Within 14 days, we noticed increased bruising, but she was officially diagnosed with ITP (idiopathic thrombocytopenic purpura) 2 months later when we noticed severe bruising and petechiae.  She was diagnosed with a platelet count of 7000.  She was treated with WinRho by IV.  She was treated many times with WinRho IV for the first year after diagnosis and also with high dose prednisone.  We were urged to have her spleen removed but opted not to and saw a different MD who recommended "watching and waiting" which we have done for the past 4 years.  She has now attained a higher platelet count but it is not normal.  Several MD's have told us that it is "possible" it was a result of the flu shot.  She has not been affected for half of her life (5.5 years). 12/1/08-records received-1/30/03-presented to ED with C/O thrombocytopenia. Petechial rash. Five day history of bruises and petechiae.   Presented again on 2/14/03 with platelets of 50,000 and new petechiae. DX idiopathic thrombocytopenia purpura. 1/26/2010 She still has a low platelet count-it has never reached a normal count since she was diagnosed with "ITP" in January of 2003. Symptoms of brusing started 2 weeks after the vaccine was give, and continues 6 years later.
Dose given outside of approved age range. Otherwise, having common side effects - fever 101.1, hot/cold flashes, headache, fatigue, dizzy spells.
Within 5 days of my son being vaccinated, he began to exhibit welts upon his torso and upper leg/groin region. Initially, these welts varied in size ranging approximately 6-12 inches in length & diameter. Twelve hours after these welts initially appeared, they began to grow in number and in extreme size, ultimately covering his entire body. The welts would also consistently disappear and reappear in different locations on his entire body. Per his explanation, these welts burned and itched immensely. He also experienced light-headedness, weakness and moderate fatigue. In addition to this, he experienced numbness & tingling in his lower extremities and they were cold to the touch.  He was seen at an urgent care the same day as the reaction and then ultimately the emergency 16 hours later when his body was covered in welts. He received a diagnosis of both urticaria and rash. I was given the instruction for him to take antihistamines and he was prescribed hydrocortisone cream to apply topically. We implemented the prescribed regimen, and followed up with his pediatrician?s office the next day. 24 hours since the reaction, the welts have diminished moderately. They are still somewhat visible, but per his demeanor, he seems to be feeling somewhat better.  To our surprise, no further medical tests and or labs were performed to determine a proper diagnosis by the urgent care, emergency room or the pediatrician?s office. Additionally, no further medical investigation was ordered to determine if this reaction could be due to any other condition or reaction to any environmental source.
2 hours after shot I felt weak for 2 hours  I started to get an itchy rash the same night and my left arm swelled. The shot location in my left arm itched a lot. I scratched it, it bled. It became a large hole. 3 days later approximately, I start feeling very very tired. It got progressively worse . I then developed " brain fog". I have barely been able to work since then.. I believe I started to recover yesterday but not completely sure yet. I also developed a painful tumor in my right arm pit that lasted for a few days. It has since gone away. It was approximately 3/4 " in size. It developed overnight.
p/vax pt Dx w/intussusception; bloody stool which was reduced w/ an air-contrast enema & sent home from ER; improved 6/23
Had hives and rash; Had hives and rash; This is a spontaneous report received from a contactable consumer. A female patient of an unspecified age received first dose of BNT162B2 (Pfizer-BioNTech Covid-19 Vaccine, solution for injection, Lot number and expiry date were not reported) via an unspecified route of administration as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced hives and rash. The events were assessed as non-serious. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
29 yr old student presents to clinic for c/o significant fatigue and fogginess for > 1 month. Reports receiving the Johnson and Johnson vaccine on July 12 2021 and the next day began feeling a lack of focus, lack of energy and that even simple tasks made him feel like he was over exerting himself. He now feels this is negatively impacting his classroom and performance (was grounded from duties by last week when appointment was made). States he sleeps well at night and wakes up feeling rested, but then feels fatigued about 1-2 hours after waking up. Reports getting 7-8 hours of sleep at night and does not get up during the night. Reports he has not changed his diet, he has decreased his physical activity because it wears him out even with a light exercise routine. Denies significant stressors, no recent illnesses. No fevers/chills/night sweats. No recent weight gain or loss.  When evaluated in 17 Sep 2021, he reported that after getting the vaccination, he felt like he was drunk, and tried drinking coffee to "wake up" but that he is just not improving. Reported that he kept going to classes despite feeling off and fatigued, but eventually realized it was not improving and he needed to stop classes for himself for safety reasons.
administration of Bexsero instead of Menveo; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB298A, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 17th August 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 17th August 2021, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: Health care professional reported administration of Bexsero instead of Menveo to a patient which led to wrong vaccine administered. The reporter consented to follow up.
client was administered vaccine by IM inj. LD in a semi fowlers in private room at 06:20pm. Client remained alert and moved to chair in sitting position. client then had an episode of syncope in chair and was held upright. client had reduced consciousness but was able to respond verbally to voice. client was assist of two to a wheel chair and moved back to private room and administered O2 via NRB @ 4lpm.  Client responded well and quickly, was more alert and oriented x3. client given orange juice at 06:30 and was fully alert and orientated, talkative and calm. O2 off at 06:35. Continued to monitor symptoms q 5 mins for 30 mins. Client is an athletic runner. His BP remained in the 92/48 range and his HR at 54. Client was released 06:55.
This spontaneous report was received from a licensed practical nurse and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant medications was provided. On 20-JUN-2017, the patients were inadvertently vaccinated subcutaneously with improperly stored single doses of VARIVAX injection (lot # M044347, expiration date: 04-NOV-2018; exact doses were not reported). The doses of VARIVAX were reconstituted with a properly stored MERCK STERILE DILUENT. The reporter stated that the administered doses of VARIVAX were stored at temperature range between 15 degrees Fahrenheit (F) to 46 degrees F for 30 minutes on an unknown date. Previous temperature excursions included storage at the temperature in the range of 6 degrees F to 14 degrees F for 5 hours 49 minutes on unknown dates. Data logger was used to detect temperature excursions. No adverse effects were reported. No product quality complaint was involved. This is one of two reports received from the same reporter. Additional information is not expected because there was no consent to contact the reporter. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to PROQUAD and VARIVAX. {Additional information has been requested. / Additional information is not expected.} Sender's Comments: US-009507513-1706USA010767.
Papular macular eruption rash moderate on the left upper outer thigh. Child appears other wise well with stable vital signs, good appetite alert and happy disposition, in no acute distress.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021 at 1:08 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Apr-2021 at 1:08 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 37.49.  Concomitant medication of the patient was not reported.  Batch number 007C21A underwent temperature excursion on 27-Apr-2021 with temperature of 35 degrees Fahrenheit at 09:00 AM. These vials were moved to fridge on 19-Apr-2021 and beyond use date for the vials was reported as 19-May-2021. The vaccines moved to clinic on 27-Apr-2021. Storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination. Vials were only punctured right before administration. Vaccines were not frozen at time of administration and prior to administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. The reporter reported that, no data logger reports were available and fisher brand traceable temperature monitor was used to record hourly temperatures.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-566976 (Patient Link).
This literature marketed report has been received from the authors of a published literature article, titled as stated above, and refers to a 6-months-old female patient. The patient was homozygous for a newly identified large deletion that removed the last six exons of TYK2. She also had generalized HSV infection and allergic dermatitis (also reported as atopy).   On an unknown date, the patient was vaccinated with bcg live (BCG LIVE) (strength, dose, lot #, expiration date and route of administration were not provided) for tuberculosis bladder.  On an unknown date, also reported as at the age of 6-mo-old, the patient developed BCG-itis following bcg live (BCG LIVE) vaccination. On an unknown date, reported as at the age of 1 year old, the patient presented disseminated BCG-osis( submandibular, cervical,and axillary). She was treated with anti-tuberculosis (TB) drugs. The outcome of the events was unknown.   The reporter considered both events to be related to bcg live (BCG LIVE). Upon internal review, the events of BCG-itis and disseminated BCG disease were determined to be medically significant.  A copy of the published article is attached as further documentation of the patient's experience.  This is one of several reports derived from the same literature article. ; Sender's Comments:  US-009507513-2212USA006304:
11/12/21 presents to EC ED for "lightheadedness, dizziness, unsteadiness and confusion". PMHx "BPH, CAD s/p CABG, mitral valve replacement, severe aortic stenosis, HTN".
Symptoms-felt shaky, light-headed, nauseous, with fever and diarrhea. Symptoms began approximately 12 hours after injection.  At 24 hours post vaccine fever 101 degrees Farenheit.  Symptoms lasted approimately 36 hours.
A report has been received from a Health Professional concerning, a patient of unknown gender, who received FLUMIST (intranasal). FLUMIST (intranasal) was started on an unknown date. The parent of an 18 month child who was given FLUMIST, want to know of any side effects that she should watch for after he child was given the FLUMIST. The outcome of the event of administration of FLUMIST to a child younger than 2 years of age was unknown. The report was considered to be non-serious.
high (102F) fever beginning day after vaccination, extreme fatigue and weakness, inability to sit or stand without feeling light-headed, nauseous, and sweating, fever subsided after two days but weakness persisted and prevented standing for more than a few minutes for 8 days after vaccination, shortness of breath, chest pressure, and heart palpitations began 3-4 days after vaccination, first the shortness of breath was constant then gradually subsiding in duration ,almost one month after vaccination it is almost gone, but the heart palpitations are persisting, and most noticeable in the evening when lying still
5cm diameter urticarial (wheal & flare) rxn; otherwise no sx;
palpitations, dizziness, chills and "wet from head to toe". Note; patient did not eat yet today and arrived at 5am.
Laryngiospasm severe Mottled skin 3 days later most severe abdominal pain epigastric Night sweats. Pain or days then distended sore abdomen.
Rapid pulse  episodes over a period of 6 months, continually becoming more frequent, in the end it was every other day and would start around 11 p.m. and continue through night.  Saw a cardiologist who did an EKG (fine) and echo April 11th (fine), and eventually a heart monitor (April 18th) which meant I had to stop swimming for 2 weeks (I do laps every other day for 45 min to an hour.  2nd day after heart monitor, episodes stopped,  Have since started swimming again (May 2nd), but episodes have not re-appeared.
Patient contracted COVID after being fully vaccinated Cough, Congestion, Headache, Body Aches, Fever, Fatigue, Chills
Reaction to first vaccine (6/12/2021) -Fever for 24 hours Took 2 doses of Tylenol (every 6 hours)
I have enlarged/bulky abdominal lymph nodes,1 being  a 9cm mass of lymph nodes in my upper abd.  I feel fine, my labs are all good, Drs. can't explain it??     ***I don' know if this is related to COVID vaccine, but thought I should tell you in case anyone else is having similar symptoms.
Patient is breakthrough case with Moderna. First dose on 2/8/21 and second on 3/5/21. Vaccine info above.Tested antigen positive on 7/5 at Hospital. Tested PCR Negative on 7/9. Patient presented to ER with abdominal pain, nausea, generalized weakness, loss of appetite, significant sweats, and diarrhea. Patient stated this had started about 5 fays prior. Patient received Normal Saline IV fluids 1000 mL and ivermectin in the ER. Patient was transferred to floor on 7/9 and was still inpatient when this nurse called for follow up on 7/14.
So, on 0713/21 I went to the  Hospital and asked for Moderna.  I am 100% certain that I was given Moderna.  I did not check my vaccine card after I left the facility until today.  I left the card at home today.  My second shot was today.  I told the workers that I needed the Moderna shot.   I was given the Moderna.  So, on my vaccine card it shows that I was given Pfizer in July.  IN calling the hospital, I was advised to contact this site and sign up/in.  Ooops..
Within a few minutes of getting the vaccine her head started pounding and her eyes felt like they were going to pop out of her head. Paramedics came to her aide. Her blood pressure  was ski high (170/100). Paramedic told her to sit there and drink water. Went home and laid down until evening. Then when she went to the bathroom she had a lot of  bubbles in the toilet. She had not had that since her kidneys failed. That continued through the weekend. She called the doctor Monday morning and he told her to get lab work done on Tuesday morning because she had already taken her morning meds. Wednesday morning the lab called her to tell her to go straight to the emergency room because her kidneys were failing again. They were trying to save the kidney. They said there was a lot of fluid, so they rushed her to surgery to put in a drainage bag. She was admitted for a week. They determined after a few days that the drainage bag was not working and took it out. Then they out in a stint.  She kept the stint in for a month. But while she was in the hospital they performed a kidney biopsy to see if the kidney was still working. They determined it was not working. She has a family member now that is getting tested to see if she can donate a kidney. She is now in dialysis 3 days a week, 3.5 hours each time. Has been in and out of the hospital since for multiple reasons. Has had to have catheters replaced and placed on multiple medications.
Woke from a deep at 3am gasping for breath. I have very labored breathing and racing heart. Feels like a heavy weight on my chest making it hard to breathe.  I have had very labored breathing for 75 minutes now and if gets any worse I will seek medical attention. I am allergic to Tetanus and had respiratory distress similar to this. I am a very fit, healthy woman at 5?1? and 115 lbs with no medical conditions.
Pt woke up next morning with fever 102 and achiness and generalized unwell feeling. (flu-like) took a Tylenol and two hours later fever down to 99. She was going to continue to monitor and take Tylenol if keeps getting fever 102.
Patient in Clinic for counseling/vaccinations in preparation for trip planned for December. He was counseled on need for Hepatitis A and Typhoid vaccines and was advised that these vaccines were generally well tolerated, and provided with CDC VIS educational material. Typhoid vaccine was administered to left deltoid, with no immediate reaction. Hep A was administered and patient described discomfort at the injection site, which is a common reaction since the vaccine is a larger volume (1mL) than other vaccines. He was instructed to move his arm to disperse the medication in his muscle. Within a few seconds he stated that he felt hot and dizzy. He became very pallid, clammy and his head fell to his right side, he had uncoordinated movements of BUE. He remained unresponsive for approx. one minute. His breathing was shallow but regular, no difficulty breathing. SpO2 >97%. He returned to consciousness, and was able to answer orientation questions and follow simple commands. He then had an episode of emesis and lost consciousness for a second time. He was unresponsive for approx. 20-30 secs. He was incontinent of bladder and possibly of stool. When he returned to consciousness he remained so. He was supported by nursing staff and remained seated throughout. Attending physician called to clinic at onset of symptoms. Rapid response team alerted - transported patient to ED for further eval. At time of transfer he was alert, oriented, VS WNL, pallor resolving.
SWELLING IN LEFT PECTORIAL AREA; huge bulge from pectoral area to the axillary area; REDNESS AT INJECTION SITE; FEVER; ACHES; SWELLING; COULDENT SLEEP WELL; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (COULDENT SLEEP WELL), SWELLING (SWELLING IN LEFT PECTORIAL AREA), PAIN (ACHES), SWELLING (SWELLING) and SWELLING (huge bulge from pectoral area to the axillary area) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02S(or5)A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced SLEEP DISORDER (COULDENT SLEEP WELL), PAIN (ACHES), SWELLING (SWELLING), INJECTION SITE ERYTHEMA (REDNESS AT INJECTION SITE) and PYREXIA (FEVER). On 05-Mar-2021, the patient experienced SWELLING (SWELLING IN LEFT PECTORIAL AREA) and SWELLING (huge bulge from pectoral area to the axillary area). At the time of the report, SLEEP DISORDER (COULDENT SLEEP WELL), SWELLING (SWELLING IN LEFT PECTORIAL AREA), PAIN (ACHES), SWELLING (SWELLING), SWELLING (huge bulge from pectoral area to the axillary area), INJECTION SITE ERYTHEMA (REDNESS AT INJECTION SITE) and PYREXIA (FEVER) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: No specific follow-up information recorded.
I am unsure if the patient suffered any adverse effects.  She is under 65 years old and received the Prevnar 13 vaccine from her doctor's office.  I noticed this when I entered her flu shot into database for immunizations called agency.  It was on her record being given on 4/30/19.  On our Immunization Consent Form, she marked that she has no health issues.  I believe they inappropriately gave the Prevnar immunization.  Unfortunately, I have noticed this is a widespread issue.
First symptoms were metallic taste and hot flashes.  Progressed to hands shaking, lightheaded, both arms tingling, sciatic nerve pain in right leg worsened (previous condition), and jitter feeling in body.  At doctors, noted upon standing from sitting and lying down, blood pressure dropped but heart rate increased.  Stools became soft.  Fever developed next day.  Treatment was fluids and rest.